Results 341 to 350 of about 4,376,164 (395)
Some of the next articles are maybe not open access.
[Antiangiogenic agents and gastrointestinal cancers].
Gastroenterologie clinique et biologique, 2008The role of angiogenesis in tumor development and the identification of VEGF as a key factor in this process have recently led to the development of anti-angiogenic agents in the treatment of cancer. Among them, the major are those targeting the VEGF pathway, including anti-VEGF antibodies (bevacizumab) and VEGF receptor tyrosine kinase inhibitors ...
A, Lièvre +3 more
openaire +1 more source
Calcium-channel blocking agents for gastrointestinal disorders
The American Journal of Cardiology, 1985Calcium-channel blocking agents have a potential role in regulation of gastrointestinal tract function by decreasing smooth muscle contraction and possibly inhibiting cellular secretion. Most studies to date have concentrated on the ability of these drugs to inhibit smooth muscle contraction. Verapamil and diltiazem have been shown in animals (opossum,
openaire +2 more sources
Nitric oxide-modulating agents for gastrointestinal disorders
Expert Opinion on Investigational Drugs, 2005Almost 20 years after the identification of the biological role of nitric oxide (NO), the full therapeutic potential of novel agents that mimic the activity of NO or interfere with its synthesis has yet to be realised for utilities involving the gastrointestinal tract.
openaire +2 more sources
Effects of Pharmacological Agents on Gastrointestinal Motility
Veterinary Clinics of North America: Equine Practice, 1989The control mechanisms of gastrointestinal motility are complex. Extrinsic neurohormonal effects modulate an intrinsic system, often called the "gut brain," composed of nervous and neuropeptide components. To exert pharmacologic influence on GI motility, use is made of agents that mimic the external control system.
openaire +2 more sources
[Synthesis of gastrointestinal agents].
Zeitschrift fur Gastroenterologie, 1976The importance of syntheses of biologically active polypeptides especially of gastrointestinal hormones for medical research, is analyzed; six points, as the main goals of a synthetic approach, are discussed with respect to their special significance and are confirmed by six examples.
openaire +1 more source
Recent Advances in Gastrointestinal Prokinetic Agents
2006Publisher Summary This chapter discusses various gastrointestinal prokinetic agents, such as dopamine D 2 receptor antagonists, serotonin 5-hydroxytryptamine (5-HT 4 ) receptor agonists, serotonin 5-HT 3 receptor agonists, cholecystokinin CCK a receptor antagonists, motilin receptor agonists, and μ -opioid receptor antagonists.
David A. Sandham +1 more
openaire +1 more source
Recent developments in gastrointestinal prokinetic agents
Expert Opinion on Therapeutic Patents, 2008Background: Prokinetic agents are employed to reverse impaired gastrointestinal motility arising from functional disorders such as constipation-dependent irritable bowel syndrome and functional dyspepsia, as well as chronic constipation and gastro-oesophageal reflux disease.
openaire +1 more source
New treatment strategies for advanced-stage gastrointestinal stromal tumours
Nature Reviews Clinical Oncology, 2022Lillian R. Klug +3 more
semanticscholar +1 more source